Abstract: The invention provides pgsA polypeptides and polynucleotides encoding pgsA polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing pgsA polypeptides to screen for antibacterial compounds.
Type:
Grant
Filed:
February 20, 1998
Date of Patent:
September 10, 2002
Assignee:
SmithKline Beecham Corporation
Inventors:
David John Holmes, Chantal Myriam Petit, Christopher Michael Traini, Richard Lloyd Warren
Abstract: The invention provides birA polypeptides and polynucleotides encoding birA polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing birA polypeptides to screen for antibacterial compounds.
Type:
Grant
Filed:
January 26, 1999
Date of Patent:
September 10, 2002
Assignee:
SmithKline Beecham Corporation
Inventors:
Jianzhong Huang, Howard Kallender, Damien McDevitt, Stephanie Van Horn, Daniel R Sylvester
Abstract: The invention provides ribB polypeptides and polynucleotides encoding ribB polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing ribB polypeptides to screen for antibacterial compounds.
Inventors:
Michael Terence Black, Martin Karl Russell Burnham, Jason Craig Fedon, John Edward Hodgson, David Justin Charles Knowles, Michael Arthur Lonetto, Richard Oakley Nicholas, Leslie Marie Palmer, Julie M Pratt, Raymond Winfield Reichard, Martin Rosenberg, Christopher Michael Traini, Judith M Ward, Richard Lloyd Warren
Abstract: The invention provides rnc polypeptides and DNA (RNA) encoding rnc polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing rnc polypeptides to screen for antibacterial compounds.
Type:
Grant
Filed:
December 16, 1998
Date of Patent:
September 3, 2002
Assignee:
SmithKline Beecham Corporation
Inventors:
Michael Arthur Lonetto, Martin Rosenberg
Abstract: The invention provides ratC polypeptides and polynucleotides encoding ratC polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing ratC polypeptides to screen for antibacterial compounds.
Abstract: The invention provides dnaB polypeptides and polynucleotides encoding dnaB polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing dnaB polypeptides to screen for antibacterial compounds.
Type:
Grant
Filed:
April 5, 2000
Date of Patent:
July 16, 2002
Assignee:
SmithKline Beecham Corporation
Inventors:
David Lawrence Earnshaw, Earl William May, Damien McDevitt
Abstract: The invention provides histidine kinase polypeptides and polynucleotides encoding histidine kinase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing histidine kinase polypeptides to screen for antibacterial compounds.
Abstract: The invention provides 509HK polypeptides and polynucleotides encoding 509HK polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing 509HK polypeptides to screen for antibacterial compounds.
Type:
Grant
Filed:
May 4, 2000
Date of Patent:
June 18, 2002
Assignee:
SmithKline Beecham Corporation
Inventors:
Weonhye Bae, Sanjoy Biswas, Martin K. R. Burnham, John P. Throup, Stephanie Van Horn, Richard L. Warren, Jr.
Abstract: Methods are disclosed for identifying an RNA fragment that mimics the structure of a defined or undefined target RNA molecule to which a compound binds inside of a cell resulting in retardation of cell growth or cell death. Methods using these RNA fragments for identifying unknown compounds of pharmaceutical interest, and for identifying unknown RNA targets for use in treating disease are disclosed. These methods and compositions are used in screening for novel antibiotics, bacteriostatics, or modifications thereof or for identifying compounds useful to alter expression levels of proteins encoded by mRNA. The methods involve providing random DNA fragments from DNA which encodes RNA target molecules, cloning such fragments to create a plasmid library of same; transfecting cells which contain the native RNA target molecule with the plasmid library and exposing the cells to one or more of test compounds.